VTRSViatris

Health care · Pharmaceuticals · Nasdaq

Viatris is a global healthcare company whose breadth and scale we believe make it uniquely positioned to address healthcare needs globally. 10-K, Item 1

Headquarters: Canonsburg, PA
CEO: Scott A. Smith
Next results: around Feb 25, 2027

Compare with peers → Embed

RevenueFY2018–25 $14.3B−3.0% FY2024: $14.7B 10-K FY2025 · XBRL Net incomeFY2018–25 −$3.5B FY2024: −$634.2M 10-K FY2025 · XBRL Free cash flowFY2018–25 $1.9B−2.0% FY2024: $2.0B 10-K FY2025 · XBRL Operating marginFY2018–25 -18.6%−18.7 pts 7.9% in FY2018 10-K FY2025 · XBRL

What changed

10-K filed Feb 26, 2026 against Feb 27, 2025

Area	What changed	Source
Risk factors	18 new paragraphs, nothing like them in the previous 10-K	10-K Item 1A
Accounting checks	10 other checks clear	10-K · XBRL
Insiders	No open-market buys in the last 90 days	Form 4
Filings	2 in the last 30 days	EDGAR

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

What's new, in their words

10-K filed Feb 26, 2026

Paragraphs in Risk Factors that were not in the 10-K filed 2025-02-27. Quoted as filed.

As a result of the EWSR initiated in 2025, the Company has identified three strategic imperatives that will drive our future and position the Company for sustainable growth by (i) driving our base business through executing successful launches, focusing on supply chain continuity, evolving our generics portfolio over time towards more…
10-K, Item 1A

All 18 new paragraphs →

Accounting checks

latest 10-K

10 of 10 clear 0 worth a look. Checks, not verdicts.

✓
Receivables -5.9% vs revenue -3.0% (-2.9 pts)
✓
Cash from operations $2.3B vs net income −$3.5B (FY ending 2025-12-31)
✓
Inventory +3.8% vs revenue -3.0% (+6.7 pts)
✓
Same auditor in both 10-Ks: DELOITTE & TOUCHE LLP
✓
No statement of substantial doubt about going concern
✓
No 8-K item 4.02 in the last 2 years
✓
No NT 10-K or NT 10-Q in the last 2 years
✓
No sentence in the 10-K concludes that controls were not effective because of a material weakness
✓
No 8-K item 2.06 in the last 2 years
✓
No 8-K item 1.03 in the last 2 years

How each check works, with sources →

In the last 30 days

All filings →

Nov 5, 20268-K Quarterly results, Other events 8-K items 2.02, 8.01
Nov 5, 202610-Q Quarterly report (10-Q) period ended Sep 30, 2026

Get an email when this changes: new risk paragraphs, accounting items, insider purchases, a new 10-K or 10-Q. RSS feed

Work on VTRS in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/VTRS/export.csv") into a cell.